BLRX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BioLineRx Ltd

NASDAQ | BLRX

3.67

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 5, 2025)

$15.99M

Market Cap

-

P/E Ratio

-6

EPS

$26.80

52 Week High

$2.29

52 Week Low

HEALTHCARE

Sector

BLRX Chart

Recent Chart
Price Action

BLRX Technicals

Tags:

BLRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $29M
Cost Of Revenue $9.3M
Costof Goods And Services Sold $9.3M
Operating Income -$20M
Selling General And Administrative $18M
Research And Development $9.1M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$7.3M
Interest Income $1.8M
Interest Expense $9.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.1M
Income Before Tax -$9.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.2M
Comprehensive Income Net Of Tax -
Ebit -$147K
Ebitda $3.9M
Net Income -$9.2M

Revenue & Profitability

Earnings Performance

BLRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $39M
Total Current Assets $27M
Cash And Cash Equivalents At Carrying Value $10M
Cash And Short Term Investments $10M
Inventory $3.1M
Current Net Receivables $3.9M
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $10M
Intangible Assets Excluding Goodwill $10M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $9.1M
Other Current Assets $534K
Other Non Current Assets -
Total Liabilities $25M
Total Current Liabilities $15M
Current Accounts Payable $5.6M
Deferred Revenue -
Current Debt -
Short Term Debt $5M
Total Non Current Liabilities $10M
Capital Lease Obligations $1.6M
Long Term Debt $9M
Current Long Term Debt $4.5M
Long Term Debt Noncurrent -
Short Long Term Debt Total $15M
Other Current Liabilities $4.8M
Other Non Current Liabilities -
Total Shareholder Equity $13M
Treasury Stock -
Retained Earnings -$400M
Common Stock $38M
Common Stock Shares Outstanding $80M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$44M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $4.1M
Capital Expenditures $54K
Change In Receivables -
Change In Inventory -$1.2M
Profit Loss -
Cashflow From Investment $29M
Cashflow From Financing $21M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.2M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $29M
Cost Of Revenue $9.3M
Costof Goods And Services Sold $9.3M
Operating Income -$20M
Selling General And Administrative $18M
Research And Development $9.1M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$7.3M
Interest Income $1.8M
Interest Expense $9.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.1M
Income Before Tax -$9.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.2M
Comprehensive Income Net Of Tax -
Ebit -$147K
Ebitda $3.9M
Net Income -$9.2M

BLRX News

BLRX Profile

BioLineRx Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.

NXTT
+2.65%
$0.14
NVDA
-2.70%
$167.02
HOUR
+93.12%
$3.65
CGBS
-39.47%
$0.03
PRSO
+68.70%
$1.38
KVUE
-9.34%
$18.62
GNPX
+47.39%
$0.22
ISPC
+27.42%
$0.85
TSLA
+3.63%
$350.84
SNAP
+3.10%
$7.31
SOUN
+7.29%
$14.26
YAAS
-63.98%
$0.10
AAL
+1.71%
$13.08
RIVN
+3.72%
$14.21
PLTR
-1.94%
$153.11
VEEE
+46.39%
$2.84
AVGO
+9.40%
$334.89
AMD
-6.58%
$151.13
GELS
+62.50%
$1.56
SOFI
+0.86%
$25.60
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
WBD
+2.88%
$12.11
HOOD
-1.61%
$101.25
MARA
+0.52%
$15.19
NIO
-2.93%
$5.95
INTC
-0.48%
$24.49
AAPL
-0.03%
$239.69
LYT
-16.77%
$0.09
IXHL
-9.48%
$0.52
BBD
+3.58%
$3.18
ETHD
-2.46%
$3.56
DNN
+3.07%
$2.35
F
+0.51%
$11.74
GOOGL
+1.16%
$235.00
BMNR
-0.35%
$42.04
TLRY
+3.47%
$1.19
BTG
+3.21%
$4.17
BAC
-1.12%
$49.77
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ABEV
+1.82%
$2.23
NOK
-1.08%
$4.55
RIOT
+0.98%
$13.29
LULU
-18.57%
$167.80
AMZN
-1.42%
$232.33
AEO
+0.10%
$18.80
ADAP
-19.60%
$0.04
GRAB
+2.17%
$5.16
HBAN
-1.39%
$17.63
SRM
+53.27%
$10.30
ONDS
+5.62%
$5.63
PFE
+1.38%
$24.88
RGTI
-0.13%
$15.10
LDI
+26.75%
$2.89
LCID
+13.92%
$18.41
QBTS
+0.52%
$15.37
PLUG
+1.38%
$1.46
KEY
-1.25%
$18.94
EQX
+9.03%
$9.77
MSFT
-2.55%
$495.00
JBLU
-0.19%
$5.08
SBET
-3.20%
$14.93
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
MU
+5.76%
$131.37
AGNC
+1.66%
$10.37
CIFR
+1.62%
$7.52
RR
-0.39%
$2.52
WULF
+2.93%
$9.13
JOBY
+2.74%
$13.46
ETWO
0.00%
$3.30
BTE
-3.53%
$2.18
GOOG
+1.07%
$235.17
VALE
+1.36%
$10.40
MRVL
-1.20%
$63.33
T
+0.03%
$29.59
DUO
+32.81%
$3.44
HPE
+1.55%
$23.52
PBR
-1.37%
$12.21
CAN
+3.26%
$0.70
HIMS
+0.62%
$48.41
KO
-0.42%
$67.95
BURU
-5.54%
$0.14
IREN
+0.07%
$26.15
AFMD
-34.94%
$0.18
INFY
-1.26%
$16.38
CLF
+8.27%
$11.39
HL
+1.92%
$9.02
ITUB
+1.57%
$7.10
OPAD
+4.71%
$5.11
CMG
-0.84%
$41.06
NUVB
+14.03%
$3.90
SMCI
-0.71%
$40.40
KDP
-2.05%
$28.65
CSCO
-1.60%
$66.90
FIG
+0.54%
$54.86
WFC
-3.50%
$78.95
NVFY
+64.79%
$4.40
NXTT
+2.65%
$0.14
NVDA
-2.70%
$167.02
HOUR
+93.12%
$3.65
CGBS
-39.47%
$0.03
PRSO
+68.70%
$1.38
KVUE
-9.34%
$18.62
GNPX
+47.39%
$0.22
ISPC
+27.42%
$0.85
TSLA
+3.63%
$350.84
SNAP
+3.10%
$7.31
SOUN
+7.29%
$14.26
YAAS
-63.98%
$0.10
AAL
+1.71%
$13.08
RIVN
+3.72%
$14.21
PLTR
-1.94%
$153.11
VEEE
+46.39%
$2.84
AVGO
+9.40%
$334.89
AMD
-6.58%
$151.13
GELS
+62.50%
$1.56
SOFI
+0.86%
$25.60
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
WBD
+2.88%
$12.11
HOOD
-1.61%
$101.25
MARA
+0.52%
$15.19
NIO
-2.93%
$5.95
INTC
-0.48%
$24.49
AAPL
-0.03%
$239.69
LYT
-16.77%
$0.09
IXHL
-9.48%
$0.52
BBD
+3.58%
$3.18
ETHD
-2.46%
$3.56
DNN
+3.07%
$2.35
F
+0.51%
$11.74
GOOGL
+1.16%
$235.00
BMNR
-0.35%
$42.04
TLRY
+3.47%
$1.19
BTG
+3.21%
$4.17
BAC
-1.12%
$49.77
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ABEV
+1.82%
$2.23
NOK
-1.08%
$4.55
RIOT
+0.98%
$13.29
LULU
-18.57%
$167.80
AMZN
-1.42%
$232.33
AEO
+0.10%
$18.80
ADAP
-19.60%
$0.04
GRAB
+2.17%
$5.16
HBAN
-1.39%
$17.63
SRM
+53.27%
$10.30
ONDS
+5.62%
$5.63
PFE
+1.38%
$24.88
RGTI
-0.13%
$15.10
LDI
+26.75%
$2.89
LCID
+13.92%
$18.41
QBTS
+0.52%
$15.37
PLUG
+1.38%
$1.46
KEY
-1.25%
$18.94
EQX
+9.03%
$9.77
MSFT
-2.55%
$495.00
JBLU
-0.19%
$5.08
SBET
-3.20%
$14.93
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
WLGS
-5.57%
$0.04
MU
+5.76%
$131.37
AGNC
+1.66%
$10.37
CIFR
+1.62%
$7.52
RR
-0.39%
$2.52
WULF
+2.93%
$9.13
JOBY
+2.74%
$13.46
ETWO
0.00%
$3.30
BTE
-3.53%
$2.18
GOOG
+1.07%
$235.17
VALE
+1.36%
$10.40
MRVL
-1.20%
$63.33
T
+0.03%
$29.59
DUO
+32.81%
$3.44
HPE
+1.55%
$23.52
PBR
-1.37%
$12.21
CAN
+3.26%
$0.70
HIMS
+0.62%
$48.41
KO
-0.42%
$67.95
BURU
-5.54%
$0.14
IREN
+0.07%
$26.15
AFMD
-34.94%
$0.18
INFY
-1.26%
$16.38
CLF
+8.27%
$11.39
HL
+1.92%
$9.02
ITUB
+1.57%
$7.10
OPAD
+4.71%
$5.11
CMG
-0.84%
$41.06
NUVB
+14.03%
$3.90
SMCI
-0.71%
$40.40
KDP
-2.05%
$28.65
CSCO
-1.60%
$66.90
FIG
+0.54%
$54.86
WFC
-3.50%
$78.95
NVFY
+64.79%
$4.40
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.